Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Li, Qingxue ^a   Ali, Mir A ^a   Wang, Kening ^a   Sayre, Dean ^a   Hamel, Frederick G ^b   Fischer, Elizabeth R ^a   Bennett, Robert G ^b   Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E; INSULINASE; RECOMBINANT ENZYME;

ANIMAL CELL; ARTICLE; CELL SPREADING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME BINDING; HERPES ZOSTER; HUMAN; HUMAN CELL; INCUBATION TIME; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; TEMPERATURE; VARICELLA ZOSTER VIRUS; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MUTANT;

ANIMALS; CELL-FREE SYSTEM; HERPESVIRUS 3, HUMAN; INSULYSIN; MUTATION; PROTEIN CONFORMATION; VIRAL ENVELOPE PROTEINS; VIRULENCE;

HUMAN HERPESVIRUS 3;

EID: 77955313205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011327     Document Type: Article

References (71)

1. Cohen JI, Straus SE, Arvin AM (2007) Varicella-Zoster Virus Replication, Pathogenesis, and Management. In: Knipe DM, Howley PM, eds. Fields Virology, 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp 2773-2818.
2. Chen JJ, Zhu Z, Gershon AA, Gershon MD (2004) Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell 119: 915-926.
3. Li Q, Ali MA, Cohen JI (2006) Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 127: 305-316.
4. Mallory S, Sommer M, Arvin AM (1997) Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol 71: 8279-8288.
5. Ali MA, Li Q, Fischer ER, Cohen JI (2009) The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection. Virology 386: 270-279.
6. Li Q, Krogmann T, Ali MA, Tang WJ, Cohen JI (2007) The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulindegrading enzyme, a VZV receptor. J Virol 81: 8525-8532.
7. Berarducci B, Ikoma M, Stamatis S, Sommer M, Grose C, et al. (2006) Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. J Virol 80: 9481-9496.
8. Berarducci B, Rajamani J, Zerboni L, Che X, Sommer M, et al. (2009) Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proc Natl Acad Sci U S A 107: 282-287.
9. Chesneau V, Rosner MR (2000) Functional human insulin-degrading enzyme can be expressed in bacteria. Protein Expr Purif 19: 91-98.
10. Perlman RK, Rosner MR (1994) Identification of zinc ligands of the insulindegrading enzyme. J Biol Chem 269: 33140-33145.
11. Leissring MA, Farris W, Wu X, Christodoulou DC, Haigis MC, et al. (2004) Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem J 383: 439-446.
12. Li P, Kuo WL, Yousef M, Rosner MR, Tang WJ (2006) The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem Biophys Res Commun 343: 1032-1037.
13. Bennett RG, Duckworth WC, Hamel FG (2000) Degradation of amylin by insulin-degrading enzyme. J Biol Chem 275: 36621-36625.
14. Bennett RG, Heimann DG, Hamel FG (2009) Degradation of relaxin family peptides by insulin-degrading enzyme. Ann N Y Acad Sci 1160: 38-41.
15. Duckworth WC, Kitabchi AE (1974) Insulin and glucagon degradation by the same enzyme. Diabetes 23: 536-543.
16. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, et al. (2003) Insulindegrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100: 4162-4167.
17. Dimitrov DS (2004) Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol 2: 109-122.
18. Marsh M, Helenius A (2006) Virus entry: open sesame. Cell 124: 729-740.
19. Cole NL, Grose C (2003) Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus. Rev Med Virol 13: 207-222.
20. Park C, Marqusee S (2006) Quantitative determination of protein stability and ligand binding by pulse proteolysis. Curr Protoc Protein Sci Chapter 20: Unit 20 11.
21. Delos SE, Godby JA, White JM (2005) Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J Virol 79: 3488-3499.
22. Matsuyama S, Taguchi F (2009) Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J Virol 83: 11133-11141.
23. Perlman RK, Gehm BD, Kuo WL, Rosner MR (1993) Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J Biol Chem 268: 21538-21544.
24. Harper DR, Kangro HO (1990) Lipoproteins of varicella-zoster virus. J Gen Virol 71 (Pt 2): 459-463.
25. Li Q, Turk SM, Hutt-Fletcher LM (1995) The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69: 3987-3994.
26. Spear PG (2004) Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 6: 401-410.
27. Carpenter JE, Henderson EP, Grose C (2009) Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus. J Virol 83: 6917-6921.
28. Maresova L, Pasieka TJ, Homan E, Gerday E, Grose C (2005) Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope. J Virol 79: 997-1007.
29. Sato H, Callanan LD, Pesnicak L, Krogmann T, Cohen JI (2002) Varicellazoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. J Virol 76: 11012-11023.
30. Cohen JI, Sato H, Srinivas S, Lekstrom K (2001) Varicella-zoster virus (VZV) ORF65 virion protein is dispensable for replication in cell culture and is phosphorylated by casein kinase II, but not by the VZV protein kinases. Virology 280: 62-71.
31. Keller PM, Neff BJ, Ellis RW (1984) Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol 52: 293-297.
32. Dveksler GS, Gagneten SE, Scanga CA, Cardellichio CB, Holmes KV (1996) Expression of the recombinant anchorless N-terminal domain of mouse hepatitis virus (MHV) receptor makes hamster of human cells susceptible to MHV infection. J Virol 70: 4142-4145.
33. Clapham PR, McKnight A, Weiss RA (1992) Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J Virol 66: 3531-3537.
34. Snitkovsky S, Young JA (1998) Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci U S A 95: 7063-7068.
35. Damico R, Bates P (2000) Soluble receptor-induced retroviral infection of receptor-deficient cells. J Virol 74: 6469-6475.
36. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998) Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280: 1618-1620.
37. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22.
38. Tiwari V, O'Donnell C, Copeland RJ, Scarlett T, Liu J, et al. (2007) Soluble 3- O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells. J Gen Virol 88: 1075-1079.
39. Lopez M, Cocchi F, Avitabile E, Leclerc A, Adelaide J, et al. (2001) Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection. J Virol 75: 5684-5691.
40. Kwon H, Bai Q, Baek HJ, Felmet K, Burton EA, et al. (2006) Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. J Virol 80: 138-148.
41. Earp LJ, Delos SE, Park HE, White JM (2005) The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 285: 25-66.
42. Kirschner AN, Sorem J, Longnecker R, Jardetzky TS (2009) Structure of Epstein-Barr virus glycoprotein 42 suggests a mechanism for triggering receptoractivated virus entry. Structure 17: 223-233.
43. Pertel PE, Fridberg A, Parish ML, Spear PG (2001) Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279: 313-324.
44. Subramanian RP, Geraghty RJ (2007) Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc Natl Acad Sci U S A 104: 2903-2908.
45. Maresova L, Pasieka TJ, Grose C (2001) Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol 75: 9483-9492.
46. Kaletsky RL, Simmons G, Bates P (2007) Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81: 13378-13384.
47. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 80: 4174-4178.
48. Pager CT, Craft WW, Jr., Patch J, Dutch RE (2006) A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346: 251-257.
49. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, et al. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A 102: 11876-11881.
50. Kawase M, Shirato K, Matsuyama S, Taguchi F (2009) Protease-mediated entry via the endosome of human coronavirus 229E. J Virol 83: 712-721.
51. Rojek JM, Pasqual G, Sanchez AB, Nguyen NT, de la Torre JC, et al. (2009) Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel anti-viral strategy against arenaviruses. J Virol 84: 573-584.
52. Golden JW, Linke J, Schmechel S, Thoemke K, Schiff LA (2002) Addition of exogenous protease facilitates reovirus infection in many restrictive cells. J Virol 76: 7430-7443.
53. Townsley AC, Moss B (2007) Two distinct low-pH steps promote entry of vaccinia virus. J Virol 81: 8613-8620.
54. Milne RS, Nicola AV, Whitbeck JC, Eisenberg RJ, Cohen GH (2005) Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. J Virol 79: 6655-6663.
55. Nicola AV, Straus SE (2004) Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J Virol 78: 7508-7517.
56. Hambleton S, Steinberg SP, Gershon MD, Gershon AA (2007) Cholesterol dependence of varicella-zoster virion entry into target cells. J Virol 81: 7548-7558.
57. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA (2000) Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103: 679-689.
58. Narayan S, Barnard RJ, Young JA (2003) Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differences in viral infectivity. J Virol 77: 1977-1983.
59. Lynch JA, George AM, Eisenhauer PB, Conn K, Gao W, et al. (2006) Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures. J Neurosci Res 83: 1262-1270.
60. Harpaz R, Ortega-Sanchez IR, Seward JF (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5): 1-30.
61. Santos RA, Hatfield CC, Cole NL, Padilla JA, Moffat JF, et al. (2000) Varicellazoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 275: 306-317.
62. Pasieka TJ, Maresova L, Shiraki K, Grose C (2004) Regulation of varicellazoster virus-induced cell-to-cell fusion by the endocytosis-competent glycoproteins gH and gE. J Virol 78: 2884-2896.
63. Cohen JI (1998) Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis 177: 1390-1393.
64. Kimura H, Straus SE, Williams RK (1997) Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. Virology 233: 382-391.
65. Hamel FG, Upward JL, Bennett RG (2003) In vitro inhibition of insulindegrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144: 2404-2408.
66. Veettil MV, Sadagopan S, Sharma-Walia N, Wang FZ, Raghu H, et al. (2008) Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J Virol 82: 12126-12144.
67. McClain DS, Fuller AO (1994) Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. Virology 198: 690-702.
68. Wang K, Lau TY, Morales M, Mont EK, Straus SE (2005) Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level. J Virol 79: 14079-14087.
69. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
70. Nussbaum O, Broder CC, Berger EA (1994) Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virusbased assay quantitating cell fusion-dependent reporter gene activation. J Virol 68: 5411-5422.
71. Kalderon D, Roberts BL, Richardson WD, Smith AE (1984) A short amino acid sequence able to specify nuclear location. Cell 39: 499-509.